Gastrointestinal Radiography Adjunct — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for gastrointestinal radiography adjunct. 19 active patents protecting 2 drugs from 2+ originators. First major cliff: 2029. Daily refresh.

2
Approved drugs
19
Active US patents
70/100
Avg vulnerability
—
Annual revenue covered

Originators in Gastrointestinal Radiography Adjunct

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Xeris 12 patents Hikma 7 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating gastrointestinal radiography adjunct. Each bar = one year. Y-axis scaled to peak year (11 patents).

5
29
1
30
11
36
1
38
1
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Glucagen
GLUCAGON
 Xeris 12 65 — 2036-02-16
Reglan
Metoclopramide Hydrochloride
 Hikma 7 75 — 2029-12-22

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12194008 Reglan method of use 81 2029-12-22
12194009 Reglan method of use 81 2029-12-22
11628150 Reglan method of use 76 2029-12-22
11813231 Reglan method of use 76 2029-12-22
12370241 Glucagen method of use 75 2036-02-16
12377064 Reglan method of use 75 2038-11-17
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10765602 Glucagen formulation 42 2039-09-23
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22
10213487 Glucagen method of use 62 2036-02-16
8334281 Reglan method of use 68 2030-05-16
11020361 Reglan method of use 68 2029-12-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22

Related